RETRACTION: Treatment of postoperative emetic symptoms with granisetron in women undergoing abdominal hysterectomy: A randomized, double-blind, placebo-controlled, dose-ranging study (Retraction of Vol 65, Pg 321, 2004)

被引：0
|
作者：
Fujii, Yoshitaka [1 ,2 ,3 ]
Tanaka, Hiroyoshi [1 ,2 ,3 ]
Somekawa, Yoshiaki [1 ,2 ,3 ]
机构：
[1] Univ Tsukuba, Dept Anesthesiol, Inst Clin Med, Tsukuba, Ibaraki, Japan
[2] Toride Kyodo Gen Hosp, Dept Anesthesiol, Toride, Ibaraki, Japan
[3] Toride Kyodo Gen Hosp, Dept Surg, Toride, Ibaraki, Japan
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2018年 / 88卷
关键词：
D O I：
10.1016/j.curtheres.2018.03.001
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [21] RETRACTION: Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial (Retraction of Vol 31, Pg 388, 2018)
    Ismail, Alaa M.
    Abbas, Ahmed M.
    Ali, Mohammed K.
    Amin, Ahmed F.
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (06): : 1073 - 1073
  • [22] Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study
    Kellstein, DE
    Lipton, RB
    Geetha, R
    Koronkiewicz, K
    Evans, FT
    Stewart, WF
    Wilkes, K
    Furey, SA
    Subramanian, T
    Cooper, SA
    [J]. CEPHALALGIA, 2000, 20 (04) : 233 - 243
  • [23] Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms:: a double-blind, placebo-controlled randomized and dose-ranging study
    Noguchi, Masanori
    Kakuma, Tatsuyuki
    Tomiyasu, Katsuro
    Kurita, Yoshiko
    Kukihara, Hiroko
    Konishi, Fumiko
    Kumamoto, Shoichiro
    Shimizu, Kuniyoshi
    Kondo, Ryuichiro
    Matsuoka, Kei
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2008, 10 (04) : 651 - 658
  • [24] Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study (vol 58, pg 964, 2008)
    Kay
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (11): : 3518 - 3518
  • [25] Otilonium bromide in irritable bowel syndrome:A dose-ranging randomized double-blind placebo-controlled trial
    Danuta Chmielewska-Wilkoń
    Giorgio Reggiardo
    Colin Gerard Egan
    [J]. World Journal of Gastroenterology, 2014, (34) : 12283 - 12291
  • [26] Placebo-controlled, double-blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy
    Chongsomchai, C
    Lumbiganon, P
    Thinkhamrop, J
    Ounchai, J
    Vudhikamraksa, N
    [J]. JOURNAL OF HOSPITAL INFECTION, 2002, 52 (04) : 302 - 306
  • [27] Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial
    Chmielewska-Wilkon, Danuta
    Reggiardo, Giorgio
    Egan, Colin Gerard
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) : 12283 - 12291
  • [28] Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: A double-blind, placebo-controlled, dose-ranging trial
    Bone, Henry G.
    Kiel, Douglas P.
    Lindsay, Robert S.
    Lewiecki, E. Michael
    Bolognese, Michael A.
    Leary, Elizabeth T.
    Lowe, Wing
    McClung, Michael R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12): : 4671 - 4677
  • [29] EFFICACY AND SAFETY OF LY2951742 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY IN PATIENTS WITH MIGRAINE
    Skljarevski, V.
    Oakes, T.
    Ferguson, M.
    Zhang, Q.
    Martinez, J.
    Johnson, K.
    Schacht, A.
    Due, M.
    Goadsby, P.
    Dodick, D.
    [J]. CEPHALALGIA, 2016, 36 : 42 - 42
  • [30] RETRACTION: Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study (Retraction of Vol 23, Pg 245, 2017)
    Wang, Jing
    Liu, Xi-Fang
    Feng, Chong
    Bao, Quan
    Fu, Hong-Ran
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2022, 26 (04) : 417 - 417
12345